0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lidocaine Transdermal Patch Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-8F9817
Home | Market Reports | Health | Pharmacy
Global Lidocaine Transdermal Patch Market Insights Forecast to 2028

Global Lidocaine Transdermal Patch Market Insights, Forecast to 2028

Code: QYRE-Auto-8F9817
Report
February 2022
Pages:95
QYResearch
Description
Table of Content
Tables & Figures

Lidocaine Transdermal Patch Market Outlook 2028

Due to the COVID-19 pandemic, the global Lidocaine  Transdermal Patch Market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Lidocare 5% Transdermal Patch accounting for % of the Lidocaine Transdermal Patch global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Online Pharmacies segment is altered to an % CAGR throughout this forecast period.

Lidocaine Transdermal Patch Market Analysis and Insights

Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.

Lidocaine Transdermal Patch Market Size and Share

China Lidocaine Transdermal Patch market size is valued at US$ million in 2021, while the US and Europe Lidocaine Transdermal Patch are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Lidocaine Transdermal Patch landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Lidocaine Transdermal Patch include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Lidocaine Transdermal Patch Market Scope and Segment

Lidocaine Transdermal Patch market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Lidocaine Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Lidocaine Transdermal Patch Market Segment by Type

  • Lidocare 5% Transdermal Patch
  • Lidocare 1.80% Transdermal Patch
  • Lidocare 4% Transdermal Patch

Lidocaine Transdermal Patch Market Segment By Application 

  • Online Pharmacies
  • Hospital Pharmacies
  • Clinic
  • Monomer Pharmacies
  • Chain Pharmacies
  • Other

By Company

  • Teikoku
  • Teva Pharmaceutical
  • Sorrento Therapeutics
  • Hisamitsu
  • Endo International
  • Par Pharmaceutical
  • Mylan
  • Tide Pharmaceutical (SINO BIOPHARM)

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E
1 Study Coverage
1.1 Lidocaine Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Lidocaine Transdermal Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lidocare 5% Transdermal Patch
1.2.3 Lidocare 1.80% Transdermal Patch
1.2.4 Lidocare 4% Transdermal Patch
1.3 Market by Application
1.3.1 Global Lidocaine Transdermal Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Online Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Clinic
1.3.5 Monomer Pharmacies
1.3.6 Chain Pharmacies
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts 2017-2028
2.2 Global Lidocaine Transdermal Patch Revenue Estimates and Forecasts 2017-2028
2.3 Global Lidocaine Transdermal Patch Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lidocaine Transdermal Patch Sales by Region
2.4.1 Global Lidocaine Transdermal Patch Sales by Region (2017-2022)
2.4.2 Global Sales Lidocaine Transdermal Patch by Region (2023-2028)
2.5 Global Lidocaine Transdermal Patch Revenue by Region
2.5.1 Global Lidocaine Transdermal Patch Revenue by Region (2017-2022)
2.5.2 Global Lidocaine Transdermal Patch Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lidocaine Transdermal Patch Sales by Manufacturers
3.1.1 Global Top Lidocaine Transdermal Patch Manufacturers by Sales (2017-2022)
3.1.2 Global Lidocaine Transdermal Patch Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lidocaine Transdermal Patch in 2021
3.2 Global Lidocaine Transdermal Patch Revenue by Manufacturers
3.2.1 Global Lidocaine Transdermal Patch Revenue by Manufacturers (2017-2022)
3.2.2 Global Lidocaine Transdermal Patch Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lidocaine Transdermal Patch Revenue in 2021
3.3 Global Lidocaine Transdermal Patch Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lidocaine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lidocaine Transdermal Patch Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lidocaine Transdermal Patch Sales by Type
4.1.1 Global Lidocaine Transdermal Patch Historical Sales by Type (2017-2022)
4.1.2 Global Lidocaine Transdermal Patch Forecasted Sales by Type (2023-2028)
4.1.3 Global Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
4.2 Global Lidocaine Transdermal Patch Revenue by Type
4.2.1 Global Lidocaine Transdermal Patch Historical Revenue by Type (2017-2022)
4.2.2 Global Lidocaine Transdermal Patch Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
4.3 Global Lidocaine Transdermal Patch Price by Type
4.3.1 Global Lidocaine Transdermal Patch Price by Type (2017-2022)
4.3.2 Global Lidocaine Transdermal Patch Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lidocaine Transdermal Patch Sales by Application
5.1.1 Global Lidocaine Transdermal Patch Historical Sales by Application (2017-2022)
5.1.2 Global Lidocaine Transdermal Patch Forecasted Sales by Application (2023-2028)
5.1.3 Global Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
5.2 Global Lidocaine Transdermal Patch Revenue by Application
5.2.1 Global Lidocaine Transdermal Patch Historical Revenue by Application (2017-2022)
5.2.2 Global Lidocaine Transdermal Patch Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
5.3 Global Lidocaine Transdermal Patch Price by Application
5.3.1 Global Lidocaine Transdermal Patch Price by Application (2017-2022)
5.3.2 Global Lidocaine Transdermal Patch Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lidocaine Transdermal Patch Market Size by Type
6.1.1 North America Lidocaine Transdermal Patch Sales by Type (2017-2028)
6.1.2 North America Lidocaine Transdermal Patch Revenue by Type (2017-2028)
6.2 North America Lidocaine Transdermal Patch Market Size by Application
6.2.1 North America Lidocaine Transdermal Patch Sales by Application (2017-2028)
6.2.2 North America Lidocaine Transdermal Patch Revenue by Application (2017-2028)
6.3 North America Lidocaine Transdermal Patch Market Size by Country
6.3.1 North America Lidocaine Transdermal Patch Sales by Country (2017-2028)
6.3.2 North America Lidocaine Transdermal Patch Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Lidocaine Transdermal Patch Market Size by Type
7.1.1 Europe Lidocaine Transdermal Patch Sales by Type (2017-2028)
7.1.2 Europe Lidocaine Transdermal Patch Revenue by Type (2017-2028)
7.2 Europe Lidocaine Transdermal Patch Market Size by Application
7.2.1 Europe Lidocaine Transdermal Patch Sales by Application (2017-2028)
7.2.2 Europe Lidocaine Transdermal Patch Revenue by Application (2017-2028)
7.3 Europe Lidocaine Transdermal Patch Market Size by Country
7.3.1 Europe Lidocaine Transdermal Patch Sales by Country (2017-2028)
7.3.2 Europe Lidocaine Transdermal Patch Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lidocaine Transdermal Patch Market Size by Type
8.1.1 Asia Pacific Lidocaine Transdermal Patch Sales by Type (2017-2028)
8.1.2 Asia Pacific Lidocaine Transdermal Patch Revenue by Type (2017-2028)
8.2 Asia Pacific Lidocaine Transdermal Patch Market Size by Application
8.2.1 Asia Pacific Lidocaine Transdermal Patch Sales by Application (2017-2028)
8.2.2 Asia Pacific Lidocaine Transdermal Patch Revenue by Application (2017-2028)
8.3 Asia Pacific Lidocaine Transdermal Patch Market Size by Region
8.3.1 Asia Pacific Lidocaine Transdermal Patch Sales by Region (2017-2028)
8.3.2 Asia Pacific Lidocaine Transdermal Patch Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Lidocaine Transdermal Patch Market Size by Type
9.1.1 Latin America Lidocaine Transdermal Patch Sales by Type (2017-2028)
9.1.2 Latin America Lidocaine Transdermal Patch Revenue by Type (2017-2028)
9.2 Latin America Lidocaine Transdermal Patch Market Size by Application
9.2.1 Latin America Lidocaine Transdermal Patch Sales by Application (2017-2028)
9.2.2 Latin America Lidocaine Transdermal Patch Revenue by Application (2017-2028)
9.3 Latin America Lidocaine Transdermal Patch Market Size by Country
9.3.1 Latin America Lidocaine Transdermal Patch Sales by Country (2017-2028)
9.3.2 Latin America Lidocaine Transdermal Patch Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lidocaine Transdermal Patch Market Size by Type
10.1.1 Middle East and Africa Lidocaine Transdermal Patch Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lidocaine Transdermal Patch Revenue by Type (2017-2028)
10.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Application
10.2.1 Middle East and Africa Lidocaine Transdermal Patch Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lidocaine Transdermal Patch Revenue by Application (2017-2028)
10.3 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country
10.3.1 Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lidocaine Transdermal Patch Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teikoku
11.1.1 Teikoku Corporation Information
11.1.2 Teikoku Overview
11.1.3 Teikoku Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teikoku Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teikoku Recent Developments
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Corporation Information
11.2.2 Teva Pharmaceutical Overview
11.2.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Recent Developments
11.3 Sorrento Therapeutics
11.3.1 Sorrento Therapeutics Corporation Information
11.3.2 Sorrento Therapeutics Overview
11.3.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sorrento Therapeutics Recent Developments
11.4 Hisamitsu
11.4.1 Hisamitsu Corporation Information
11.4.2 Hisamitsu Overview
11.4.3 Hisamitsu Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hisamitsu Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hisamitsu Recent Developments
11.5 Endo International
11.5.1 Endo International Corporation Information
11.5.2 Endo International Overview
11.5.3 Endo International Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Endo International Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Endo International Recent Developments
11.6 Par Pharmaceutical
11.6.1 Par Pharmaceutical Corporation Information
11.6.2 Par Pharmaceutical Overview
11.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Par Pharmaceutical Recent Developments
11.7 Mylan
11.7.1 Mylan Corporation Information
11.7.2 Mylan Overview
11.7.3 Mylan Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mylan Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Recent Developments
11.8 Tide Pharmaceutical (SINO BIOPHARM)
11.8.1 Tide Pharmaceutical (SINO BIOPHARM) Corporation Information
11.8.2 Tide Pharmaceutical (SINO BIOPHARM) Overview
11.8.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lidocaine Transdermal Patch Industry Chain Analysis
12.2 Lidocaine Transdermal Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lidocaine Transdermal Patch Production Mode & Process
12.4 Lidocaine Transdermal Patch Sales and Marketing
12.4.1 Lidocaine Transdermal Patch Sales Channels
12.4.2 Lidocaine Transdermal Patch Distributors
12.5 Lidocaine Transdermal Patch Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lidocaine Transdermal Patch Industry Trends
13.2 Lidocaine Transdermal Patch Market Drivers
13.3 Lidocaine Transdermal Patch Market Challenges
13.4 Lidocaine Transdermal Patch Market Restraints
14 Key Findings in The Global Lidocaine Transdermal Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Lidocaine Transdermal Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Lidocare 5% Transdermal Patch
    Table 3. Major Manufacturers of Lidocare 1.80% Transdermal Patch
    Table 4. Major Manufacturers of Lidocare 4% Transdermal Patch
    Table 5. Global Lidocaine Transdermal Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Lidocaine Transdermal Patch Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Lidocaine Transdermal Patch Sales by Region (2017-2022) & (M Pcs)
    Table 8. Global Lidocaine Transdermal Patch Sales Market Share by Region (2017-2022)
    Table 9. Global Lidocaine Transdermal Patch Sales by Region (2023-2028) & (M Pcs)
    Table 10. Global Lidocaine Transdermal Patch Sales Market Share by Region (2023-2028)
    Table 11. Global Lidocaine Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Lidocaine Transdermal Patch Revenue Market Share by Region (2017-2022)
    Table 13. Global Lidocaine Transdermal Patch Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Lidocaine Transdermal Patch Revenue Market Share by Region (2023-2028)
    Table 15. Global Lidocaine Transdermal Patch Sales by Manufacturers (2017-2022) & (M Pcs)
    Table 16. Global Lidocaine Transdermal Patch Sales Share by Manufacturers (2017-2022)
    Table 17. Global Lidocaine Transdermal Patch Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Lidocaine Transdermal Patch Revenue Share by Manufacturers (2017-2022)
    Table 19. Lidocaine Transdermal Patch Price by Manufacturers (2017-2022) &(USD/K Pcs)
    Table 20. Global Lidocaine Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Lidocaine Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lidocaine Transdermal Patch as of 2021)
    Table 22. Lidocaine Transdermal Patch Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Lidocaine Transdermal Patch Product Offered
    Table 24. Date of Manufacturers Enter into Lidocaine Transdermal Patch Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Lidocaine Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
    Table 27. Global Lidocaine Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
    Table 28. Global Lidocaine Transdermal Patch Sales Share by Type (2017-2022)
    Table 29. Global Lidocaine Transdermal Patch Sales Share by Type (2023-2028)
    Table 30. Global Lidocaine Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Lidocaine Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Lidocaine Transdermal Patch Revenue Share by Type (2017-2022)
    Table 33. Global Lidocaine Transdermal Patch Revenue Share by Type (2023-2028)
    Table 34. Lidocaine Transdermal Patch Price by Type (2017-2022) & (USD/K Pcs)
    Table 35. Global Lidocaine Transdermal Patch Price Forecast by Type (2023-2028) & (USD/K Pcs)
    Table 36. Global Lidocaine Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
    Table 37. Global Lidocaine Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
    Table 38. Global Lidocaine Transdermal Patch Sales Share by Application (2017-2022)
    Table 39. Global Lidocaine Transdermal Patch Sales Share by Application (2023-2028)
    Table 40. Global Lidocaine Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Lidocaine Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Lidocaine Transdermal Patch Revenue Share by Application (2017-2022)
    Table 43. Global Lidocaine Transdermal Patch Revenue Share by Application (2023-2028)
    Table 44. Lidocaine Transdermal Patch Price by Application (2017-2022) & (USD/K Pcs)
    Table 45. Global Lidocaine Transdermal Patch Price Forecast by Application (2023-2028) & (USD/K Pcs)
    Table 46. North America Lidocaine Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
    Table 47. North America Lidocaine Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
    Table 48. North America Lidocaine Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Lidocaine Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Lidocaine Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
    Table 51. North America Lidocaine Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
    Table 52. North America Lidocaine Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Lidocaine Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Lidocaine Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
    Table 55. North America Lidocaine Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
    Table 56. North America Lidocaine Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Lidocaine Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Lidocaine Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
    Table 59. Europe Lidocaine Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
    Table 60. Europe Lidocaine Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Lidocaine Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Lidocaine Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
    Table 63. Europe Lidocaine Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
    Table 64. Europe Lidocaine Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Lidocaine Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Lidocaine Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
    Table 67. Europe Lidocaine Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
    Table 68. Europe Lidocaine Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Lidocaine Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Lidocaine Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
    Table 71. Asia Pacific Lidocaine Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
    Table 72. Asia Pacific Lidocaine Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Lidocaine Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Lidocaine Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
    Table 75. Asia Pacific Lidocaine Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
    Table 76. Asia Pacific Lidocaine Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Lidocaine Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Lidocaine Transdermal Patch Sales by Region (2017-2022) & (M Pcs)
    Table 79. Asia Pacific Lidocaine Transdermal Patch Sales by Region (2023-2028) & (M Pcs)
    Table 80. Asia Pacific Lidocaine Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Lidocaine Transdermal Patch Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Lidocaine Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
    Table 83. Latin America Lidocaine Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
    Table 84. Latin America Lidocaine Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Lidocaine Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Lidocaine Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
    Table 87. Latin America Lidocaine Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
    Table 88. Latin America Lidocaine Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Lidocaine Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Lidocaine Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
    Table 91. Latin America Lidocaine Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
    Table 92. Latin America Lidocaine Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Lidocaine Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Lidocaine Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
    Table 95. Middle East and Africa Lidocaine Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
    Table 96. Middle East and Africa Lidocaine Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Lidocaine Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Lidocaine Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
    Table 99. Middle East and Africa Lidocaine Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
    Table 100. Middle East and Africa Lidocaine Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Lidocaine Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
    Table 103. Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
    Table 104. Middle East and Africa Lidocaine Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Lidocaine Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Teikoku Corporation Information
    Table 107. Teikoku Description and Major Businesses
    Table 108. Teikoku Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 109. Teikoku Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Teikoku Recent Developments
    Table 111. Teva Pharmaceutical Corporation Information
    Table 112. Teva Pharmaceutical Description and Major Businesses
    Table 113. Teva Pharmaceutical Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 114. Teva Pharmaceutical Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Teva Pharmaceutical Recent Developments
    Table 116. Sorrento Therapeutics Corporation Information
    Table 117. Sorrento Therapeutics Description and Major Businesses
    Table 118. Sorrento Therapeutics Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 119. Sorrento Therapeutics Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Sorrento Therapeutics Recent Developments
    Table 121. Hisamitsu Corporation Information
    Table 122. Hisamitsu Description and Major Businesses
    Table 123. Hisamitsu Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 124. Hisamitsu Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Hisamitsu Recent Developments
    Table 126. Endo International Corporation Information
    Table 127. Endo International Description and Major Businesses
    Table 128. Endo International Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 129. Endo International Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Endo International Recent Developments
    Table 131. Par Pharmaceutical Corporation Information
    Table 132. Par Pharmaceutical Description and Major Businesses
    Table 133. Par Pharmaceutical Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 134. Par Pharmaceutical Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Par Pharmaceutical Recent Developments
    Table 136. Mylan Corporation Information
    Table 137. Mylan Description and Major Businesses
    Table 138. Mylan Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 139. Mylan Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Mylan Recent Developments
    Table 141. Tide Pharmaceutical (SINO BIOPHARM) Corporation Information
    Table 142. Tide Pharmaceutical (SINO BIOPHARM) Description and Major Businesses
    Table 143. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 144. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Lidocaine Transdermal Patch Distributors List
    Table 149. Lidocaine Transdermal Patch Customers List
    Table 150. Lidocaine Transdermal Patch Market Trends
    Table 151. Lidocaine Transdermal Patch Market Drivers
    Table 152. Lidocaine Transdermal Patch Market Challenges
    Table 153. Lidocaine Transdermal Patch Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Lidocaine Transdermal Patch Product Picture
    Figure 3. Global Lidocaine Transdermal Patch Market Share by Type in 2021 & 2028
    Figure 3. Lidocare 5% Transdermal Patch Product Picture
    Figure 4. Lidocare 1.80% Transdermal Patch Product Picture
    Figure 5. Lidocare 4% Transdermal Patch Product Picture
    Figure 6. Global Lidocaine Transdermal Patch Market Share by Application in 2021 & 2028
    Figure 7. Online Pharmacies
    Figure 8. Hospital Pharmacies
    Figure 9. Clinic
    Figure 10. Monomer Pharmacies
    Figure 11. Chain Pharmacies
    Figure 12. Other
    Figure 13. Lidocaine Transdermal Patch Report Years Considered
    Figure 14. Global Lidocaine Transdermal Patch Sales 2017-2028 (M Pcs)
    Figure 15. Global Lidocaine Transdermal Patch Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Lidocaine Transdermal Patch Revenue 2017-2028 (US$ Million)
    Figure 17. Global Lidocaine Transdermal Patch Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Lidocaine Transdermal Patch Sales Market Share by Region (2017-2022)
    Figure 19. Global Lidocaine Transdermal Patch Sales Market Share by Region (2023-2028)
    Figure 20. North America Lidocaine Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
    Figure 21. North America Lidocaine Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Lidocaine Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
    Figure 23. Europe Lidocaine Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Lidocaine Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
    Figure 25. Asia-Pacific Lidocaine Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Lidocaine Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
    Figure 27. Latin America Lidocaine Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Lidocaine Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
    Figure 29. Middle East & Africa Lidocaine Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Lidocaine Transdermal Patch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Lidocaine Transdermal Patch in the World: Market Share by Lidocaine Transdermal Patch Revenue in 2021
    Figure 32. Global Lidocaine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
    Figure 34. Global Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
    Figure 35. Global Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
    Figure 36. Global Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
    Figure 37. North America Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
    Figure 38. North America Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
    Figure 39. North America Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
    Figure 40. North America Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
    Figure 41. North America Lidocaine Transdermal Patch Sales Share by Country (2017-2028)
    Figure 42. North America Lidocaine Transdermal Patch Revenue Share by Country (2017-2028)
    Figure 43. U.S. Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
    Figure 46. Europe Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
    Figure 48. Europe Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Lidocaine Transdermal Patch Sales Share by Country (2017-2028)
    Figure 50. Europe Lidocaine Transdermal Patch Revenue Share by Country (2017-2028)
    Figure 51. Germany Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 52. France Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Lidocaine Transdermal Patch Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Lidocaine Transdermal Patch Revenue Share by Region (2017-2028)
    Figure 62. China Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 65. India Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Lidocaine Transdermal Patch Sales Share by Country (2017-2028)
    Figure 77. Latin America Lidocaine Transdermal Patch Revenue Share by Country (2017-2028)
    Figure 78. Mexico Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Lidocaine Transdermal Patch Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Lidocaine Transdermal Patch Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Lidocaine Transdermal Patch Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Lidocaine Transdermal Patch Revenue Share by Country (2017-2028)
    Figure 87. Turkey Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Lidocaine Transdermal Patch Revenue (2017-2028) & (US$ Million)
    Figure 90. Lidocaine Transdermal Patch Value Chain
    Figure 91. Lidocaine Transdermal Patch Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global OTC Scar Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-13J12359
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Human Immunoglobulin for Intravenous Injection, Freeze Dried Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26X10925
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Isosorbide Mononitrate Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-15R11188
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Ambroxol Hydrochloride and Glucose Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10M10976
Wed Jun 19 00:00:00 UTC 2024

Add to Cart